Structure-Function Analysis of the Essential Mycobacterium tuberculosis P450 Drug Target, CYP121A1.

Area of Science:

• Biochemistry
• Structural Biology
• Medicinal Chemistry

Background:

• Cytochrome P450 CYP121A1 is a key drug target for Mycobacterium tuberculosis.
• CYP121A1 possesses unique catalytic processes and structural characteristics among P450 enzymes.
• Limited understanding exists regarding CYP121A1 active site dynamics and ligand interactions.

Purpose of the Study:

• To investigate the structural dynamics and ligand interactions of CYP121A1.
• To identify critical amino acids and structural features influencing CYP121A1 activity and selectivity.
• To explore novel inhibition mechanisms for developing anti-tuberculosis agents.

Main Methods:

• Analysis of 53 CYP121A1 crystal structures.
• Investigation of active site cavity dynamics and amino acid interactions.
• Fragment-based inhibitor screening and structural studies.

Main Results:

• Identified critical amino acids and highlighted the rigid architecture and substrate selectivity of CYP121A1.
• Revealed a novel azole drug-P450 binding mode involving a water molecule for heme coordination.
• Demonstrated that CYP121A1 can be inhibited by blocking the substrate channel or direct heme interaction.

Conclusions:

• Provides a detailed structural understanding of CYP121A1-ligand interactions.
• Offers insights into the structure-function of P450 enzymes.
• Guides the rational design of specific CYP121A1 inhibitors for novel anti-tuberculosis drug development.